Literature DB >> 19129445

Sindbis virus-based measles DNA vaccines protect cotton rats against respiratory measles: relevance of antibodies, mucosal and systemic antibody-secreting cells, memory B cells, and Th1-type cytokines as correlates of immunity.

Marcela F Pasetti1, Karina Ramirez, Aldo Resendiz-Albor, Jeffrey Ulmer, Eileen M Barry, Myron M Levine.   

Abstract

Measles remains an important cause of pediatric morbidity and mortality in developing countries, especially among infants who are too young to receive the current licensed live attenuated measles vaccine. We developed two Sindbis virus DNA vaccines encoding the measles virus hemagglutinin (pMSIN-H) and fusion proteins (pMSINH-FdU) and examined their immunogenicities and protective efficacies when administered alone or followed by the live measles virus vaccine in cotton rats. Neutralizing antibodies, mucosal and systemic antibody-secreting cells, memory B cells, and gamma interferon-secreting T cells developed after priming and increased after boosting. pMSIN-H priming conferred 100% protection against pulmonary measles, whereas pMSINH-FdU protected only in conjunction with the live measles virus vaccine boost.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19129445      PMCID: PMC2648279          DOI: 10.1128/JVI.02191-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Use of cotton rats for preclinical evaluation of measles vaccines.

Authors:  P R Wyde; K J Stittelaar; A D Osterhaus; E Guzman; B E Gilbert
Journal:  Vaccine       Date:  2000-08-15       Impact factor: 3.641

Review 2.  Vaccines: correlates of vaccine-induced immunity.

Authors:  Stanley A Plotkin
Journal:  Clin Infect Dis       Date:  2008-08-01       Impact factor: 9.079

3.  Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.

Authors:  B Schlereth; J K Rose; L Buonocore; V ter Meulen; S Niewiesk
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life.

Authors:  Nitya Nair; Hayley Gans; Linda Lew-Yasukawa; Andrea C Long-Wagar; Ann Arvin; Diane E Griffin
Journal:  J Infect Dis       Date:  2007-10-02       Impact factor: 5.226

5.  Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.

Authors:  Marcela F Pasetti; Eileen M Barry; Genevieve Losonsky; Mahender Singh; Sandra M Medina-Moreno; John M Polo; Jeffrey Ulmer; Harriet Robinson; Marcelo B Sztein; Myron M Levine
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

6.  Heterologous prime-boost strategy to immunize very young infants against measles: pre-clinical studies in rhesus macaques.

Authors:  M F Pasetti; A Resendiz-Albor; K Ramirez; R Stout; M Papania; R J Adams; F P Polack; B J Ward; D Burt; S Chabot; J Ulmer; E M Barry; M M Levine
Journal:  Clin Pharmacol Ther       Date:  2007-10-31       Impact factor: 6.875

7.  Measles virus-specific CD4 T-cell activity does not correlate with protection against lung infection or viral clearance.

Authors:  Karen Pueschel; Annette Tietz; Mary Carsillo; Michael Steward; Stefan Niewiesk
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

8.  Cytokine and chemokine gene expression after primary and secondary respiratory syncytial virus infection in cotton rats.

Authors:  Jorge C G Blanco; Joann Y Richardson; Miriam E R Darnell; Anne Rowzee; Lioubov Pletneva; David D Porter; Gregory A Prince
Journal:  J Infect Dis       Date:  2002-05-31       Impact factor: 5.226

9.  An evaluation of infant immunization in Africa: is a transformation in progress?

Authors:  L Arevshatian; Cj Clements; Sk Lwanga; Ao Misore; P Ndumbe; Jf Seward; P Taylor
Journal:  Bull World Health Organ       Date:  2007-06       Impact factor: 9.408

10.  Measles still has a devastating impact in unvaccinated populations.

Authors:  William J Moss
Journal:  PLoS Med       Date:  2007-01       Impact factor: 11.069

View more
  9 in total

Review 1.  Correlates of protection induced by vaccination.

Authors:  Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

2.  Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.

Authors:  Emily Julik; Jorge Reyes-Del Valle
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

3.  A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques.

Authors:  Jessica C Joyce; Timothy D Carroll; Marcus L Collins; Min-Hsin Chen; Linda Fritts; Joseph C Dutra; Tracy L Rourke; James L Goodson; Michael B McChesney; Mark R Prausnitz; Paul A Rota
Journal:  J Infect Dis       Date:  2018-06-05       Impact factor: 5.226

4.  Cytokine imbalance after measles virus infection has no correlation with immune suppression.

Authors:  Mary Carsillo; Kay Klapproth; Stefan Niewiesk
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

Review 5.  Plasmid DNA-based Alphavirus Vaccines.

Authors:  Kenneth Lundstrom
Journal:  Vaccines (Basel)       Date:  2019-03-08

6.  Probing Morbillivirus Antisera Neutralization Using Functional Chimerism between Measles Virus and Canine Distemper Virus Envelope Glycoproteins.

Authors:  Miguel Angel Muñoz-Alía; Stephen J Russell
Journal:  Viruses       Date:  2019-07-27       Impact factor: 5.048

Review 7.  Alphavirus-based vaccines.

Authors:  Kenneth Lundstrom
Journal:  Viruses       Date:  2014-06-16       Impact factor: 5.048

8.  Induction of neutralizing antibody response against four dengue viruses in mice by intramuscular electroporation of tetravalent DNA vaccines.

Authors:  Eakachai Prompetchara; Chutitorn Ketloy; Poonsook Keelapang; Nopporn Sittisombut; Kiat Ruxrungtham
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

Review 9.  Morbillivirus vaccines: recent successes and future hopes.

Authors:  Hubert Buczkowski; Murali Muniraju; Satya Parida; Ashley C Banyard
Journal:  Vaccine       Date:  2014-04-03       Impact factor: 3.641

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.